Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 10080589

Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
1999 Feb
First author
Blum JL

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Blum JL
      type
      Author
    2. name
      Jones SE
      type
      Author
    3. name
      Buzdar AU
      type
      Author
    4. name
      LoRusso PM
      type
      Author
    5. name
      Kuter I
      type
      Author
    6. name
      Vogel C
      type
      Author
    7. name
      Osterwalder B
      type
      Author
    8. name
      Burger HU
      type
      Author
    9. name
      Brown CS
      type
      Author
    10. name
      Griffin T
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Blum JL
      type
      Author
    2. name
      Jones SE
      type
      Author
    3. name
      Buzdar AU
      type
      Author
    4. name
      LoRusso PM
      type
      Author
    5. name
      Kuter I
      type
      Author
    6. name
      Vogel C
      type
      Author
    7. name
      Osterwalder B
      type
      Author
    8. name
      Burger HU
      type
      Author
    9. name
      Brown CS
      type
      Author
    10. name
      Griffin T
      type
      Author
    bibliography ids
    1. nci-bib-19ea426db14e449d382c8de5
    book metadata
    content sha256
    bb99448aedd8ade40196f9e1fb9b1d72ac028c55e0ca2720a306e319ad74ba32
    document type
    citation
    dois
    1. 10.1200/JCO.1999.17.2.485
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:10080589
    immutable id
    pubmed:10080589@bb99448aedd8ade40196f9e1fb9b1d72ac028c55e0ca2720a306e319ad74ba32
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    Source null
    issn print
    0732-183X
    issue
    2
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    485-93
    volume
    17
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      10080589
      provenance
      batch id
      322200bb755447812cbb
      provider
      NCBI PubMed ESummary
      record sha256
      bb0f2fb97ec9db122ccdc4dda249b81a37e2e334fb7fed3fd98baa367bc507c3
      response sha256
      943a99f9971dfe66ed403e5c181642ea57c7276fe995e9a6a8c892602df084fa
      retrieved at
      2026-09-09T23:45:33.802271+00:00
      publication date
      display
      1999 Feb
      precision
      month
      year
      1999
      publication types
      1. Clinical Trial
      2. Clinical Trial, Phase II
      3. Journal Article
      4. Multicenter Study
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/10080589/
      title
      Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer.

      Preserved source evidence · Not medical advice